Inozyme Pharma News

BofA Securities Maintains Inozyme Pharma(INZY.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsOct 25 10:34 ET

BofA Securities Maintains Inozyme Pharma(INZY.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsOct 25 08:36 ET

Needham Maintains Inozyme Pharma(INZY.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsOct 25 07:31 ET

Inozyme Pharma Price Target Maintained With a $23.00/Share by Needham

Dow JonesOct 25 07:10 ET

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM) and Inozyme Pharma (INZY)

TipRanksOct 25 06:55 ET

Inozyme Pharma Analyst Ratings

BenzingaOct 25 06:50 ET

H.C. Wainwright Maintains Inozyme Pharma(INZY.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsOct 25 06:31 ET

Inozyme Pharma Price Target Maintained With a $15.00/Share by Wedbush

Dow JonesSep 30 08:29 ET

Inozyme Pharma Analyst Ratings

BenzingaSep 30 08:19 ET

Stifel Maintains Inozyme Pharma(INZY.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsSep 12 08:32 ET

Stifel Initiates Inozyme Pharma(INZY.US) With Buy Rating, Announces Target Price $16

Moomoo NewsSep 11 16:31 ET

Jefferies Initiates Inozyme Pharma(INZY.US) With Buy Rating, Announces Target Price $17

Moomoo NewsAug 13 05:32 ET

Inozyme Pharma: A Buy Rating With Multi-Billion Dollar Market Potential and Upcoming Catalysts

TipRanksAug 13 05:14 ET

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Inozyme Pharma (INZY) and Foghorn Therapeutics (FHTX)

TipRanksAug 8 10:00 ET

Inozyme Pharma Price Target Maintained With a $14.00/Share by HC Wainwright & Co.

Dow JonesAug 8 06:54 ET

TD Cowen Maintains Inozyme Pharma(INZY.US) With Buy Rating

Moomoo NewsAug 6 18:33 ET

Inozyme Pharma: A Buy Rating Backed by Clinical Trials and Market Potential

TipRanksAug 6 13:40 ET

Needham Maintains Inozyme Pharma(INZY.US) With Buy Rating, Maintains Target Price $23

Moomoo NewsAug 6 13:32 ET

Analysts' Top Healthcare Picks: Inozyme Pharma (INZY), Glaukos (GKOS)

TipRanksJul 27 05:12 ET

Inozyme Pharma Analyst Ratings

BenzingaJul 26 11:44 ET